Clinical Trial Update: Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDS

View source ↗

Summary

This clinical trial evaluated the percentage of alveolar fibrocytes as a biomarker in patients with Acute Respiratory Distress Syndrome requiring mechanical ven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Respiratory Distress Syndrome (ARDS), Mechanical Ventilation | Status: COMPLETED